Skip to main content
. 2022 Jan 16;22:69. doi: 10.1186/s12885-022-09174-3

Table 2.

Women’s organisational preferences and adoption of health behaviours after risk feedback

Self-reported breast cancer risk

All women

N = 325

Low

N = 60

Average

N = 125

Moderate

N = 80

High

N = 60

Risk result in letter, n acceptable (%)a 251 (77.2) 53 (88.3) 104 (83.2) 61 (76.3) 33 (55.0)
Need for consultation, n yes (%) 99 (30.5) 2 (3.3) 24 (19.2) 28 (35.0) 45 (75.0)
Preferred risk counsellor, n (%)b
 General practitioner 49 (49.5) 1 (50.0) 14 (40.0) 11 (30.6) 23 (30.3)
 Oncologist 42 (42.4) 1 (50.0) 11 (31.4) 11 (30.6) 19 (25.0)
 Geneticist 37 (37.4) 2 (5.7) 10 (27.7) 25 (32.9)
 Nurse 21 (21.2) 8 (22.9) 4 (11.1) 9 (11.8)
 Radiologist
 Radiographer
Use website, n yes (%) 243 (74.8) 41 (68.3) 97 (77.6) 59 (73.8) 46 (76.7)
Screening intent, n yes (%)c 308 (94.8) 54 (90.0) 123 (98.4) 78 (97.5) 53 (88.3)
Supplemental mammography intent, n yes (%)d 47 (22.9) n/a 16 (12.8) 31 (38.8) n/a
Preferred screening interval low risk
 3-year 34 (56.7)
 4-year 20 (33.3)
 5-year 4 (6.7)
 Don’t know 2 (3.3)
Preferred screening interval high risk
 6-month 5 (8.3)
 1-year 34 (56.7)
 18-month 16 (26.6)
 2-year 3 (5.0)
 3-year 1 (1.7)
 Don’t know 1 (1.7)

All women

N = 325

Low risk

N = 60

Average risk

N = 125

Moderate risk

N = 80

High risk

N = 60

Increased breast self-exam, n yes (%) 124 (38.2) 12 (20.0) 36 (28.8) 39 (48.8) 37 (61.7)
Changed diet (%)
 Yes 77 (23.7) 7 (11.7) 20 (16.0) 23 (28.7) 27 (45.0)
 No 69 (21.2) 10 (16.7) 37 (29.6) 12 (15.0) 10 (16.7)
 No, not required 179 (55.1) 43 (71.6) 68 (54.4) 45 (56.3) 23 (38.3)
Changed exercise habits, n (%)
 Yes 86 (26.5) 16 (26.7) 28 (22.4) 16 (20.0) 18 (30.0)
 No 102 (31.4) 15 (25.0) 48 (38.4) 23 (28.8) 16 (26.7)
 No, not required 137 (42.1) 29 (48.3) 49 (39.2) 41 (51.2) 26 (43.3)
Changed alcohol intake, n (%)
 Yes 65 (20.0) 12 (20.0) 22 (17.6) 17 (21.2) 14 (23.3)
 No 107 (34.8) 17 (28.3) 47 (37.6) 23 (28.8) 20 (33.3)
 No, not required 153 (47.2) 31 (51.7) 56 (44.8) 40 (50.0) 26 (43.4)
Started medication, n yes (%)e 46 (50.0) n/a n/a 13 (31.7) 33 (66.0)
Willing to consider medication, n yes (%)f 16 (33.3) n/a n/a 13 (33.3) 3 (33.3)
Tamoxifen preference, n (%)
 Pill 73 (52.1) n/a n/a 32 (40.0) 41 (68.4)
 Cream 22 (15.7) n/a n/a 17 (21.3) 5 (8.3)
 No preference 9 (6.4) n/a n/a 8 (10.0) 1 (1.7)
 Neither 28 (20.1) n/a n/a 17 (21.3) 11 (18.3)
 Don’t know 8 (5.7) n/a n/a 6 (7.4) 2 (3.3)

a High-risk women did not receive their risk result in a letter, but were asked about a hypothetical scenario; b Percentages based on the number of women who perceived a need for a consultation, women could mark multiple options; c Based on stratified interval displayed in Fig. 1; d Based on a 4-year screening interval for low-risk women, and a 3-year screening interval for average and moderate risk women, e Based on number of women who indicated that tamoxifen was discussed with them for the PROCAS study; f Based on number of women who were eligible for preventative medication but indicated that it was not discussed with them for the PROCAS study